Pharmacogenomics — Genomics & DNA
Analyzes genetic variants that influence drug metabolism, efficacy, and adverse reaction risk. Covers 200+ medications across multiple drug classes including antidepressants, pain management, cardiovascular, and oncology drugs.
Medication selection optimization, adverse drug reaction prevention, dose adjustment guidance, and polypharmacy management.
24 biomarkers analyzed — here are the highlights
Metabolizes ~25% of all prescription drugs
Clopidogrel, PPIs, and antidepressant metabolism
Most abundant drug-metabolizing enzyme
Warfarin and NSAID metabolism
Statin transport and myopathy risk
Fluoropyrimidine toxicity risk
This test is designed for the following practice types and clinical scenarios
Other tests in Genomics & DNA that complement this one
36 biomarkers · 14-21 days
Comprehensive DNA analysis covering 36 genetic pathways across cellular, systems, and body-level processes. Provides actionable dietary and supplement recommendations based on individual genetic variants.
12 biomarkers · 10-14 days
Focused genetic analysis of methylation pathway variants including MTHFR, MTR, MTRR, BHMT, CBS, and related SNPs. Essential for understanding folate metabolism, homocysteine management, and neurotransmitter synthesis.